Plain-English translation of NCT06789770 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is investigating how the route you breathe through — nose versus mouth — affects the results of a specialized sleep test called drug-induced sleep endoscopy, which doctors use to diagnose obstructive sleep apnea. Researchers will measure what percentage of your breaths come through your nose or mouth during this test, along with a standard overnight sleep study, to see if this information helps doctors better understand your condition.
Doctors want to know whether the way you naturally breathe during sleep testing affects how they diagnose and plan treatment for sleep apnea. Understanding this could help them give you more accurate diagnoses and better treatment recommendations.
You likely qualify if…
You likely don't qualify if…
You will undergo a drug-induced sleep endoscopy as part of your regular care, where a doctor uses a small camera to examine your airway while you sleep. As part of the research, you will also have an overnight sleep study in the laboratory with special monitoring equipment that tracks whether you breathe through your nose or mouth. The study will measure your breathing patterns during different positions and maneuvers to help researchers understand how breathing route affects sleep apnea diagnosis.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States
McCabe Fund
Enrollment target
~50 participants
Started
November 2024
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Everett Seay
University of Pennsylvania
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.